Glucagon

Product manufactured by Eli Lilly And Company

Application Nr Approved Date Route Status External Links
NDA020928 None None None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

Indications And Usage For The Treatment Of Severe Hypoglycemia: Glucagon Is Indicated As A Treatment For Severe Hypoglycemia (Low Blood Sugar) Which May Occur In Patients With Diabetes Mellitus. Because Patients With Type 1 Diabetes May Have Less Of An Increase In Blood Glucose Levels Compared With A Stable Type 2 Patient, Supplementary Carbohydrate Should Be Given As Soon As Possible, Especially To A Pediatric Patient. For Use As A Diagnostic Aid: Glucagon Is Indicated As A Diagnostic Aid In The Radiologic Examination Of The Stomach, Duodenum, Small Bowel, And Colon When Diminished Intestinal Motility Would Be Advantageous. Glucagon Is As Effective For This Examination As Are The Anticholinergic Drugs. However, As Use Of Glucagon In Combination With Anticholinergic Drugs May Result In Increased Side Effects, The Use Of Glucagon In Combination With Anticholinergic Drugs Is Not Recommended.

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Glucagon

Comments